WPE & WHPE 2026 Plant Extract Factory Visit Guide

A plant extract can be described by a familiar botanical name and a persuasive active-content figure while still leaving the most important sourcing questions unanswered. Which species and plant part entered production? Where was it grown? Was the quoted ratio calculated from dry raw material or presented only as a marketing shorthand? Does the sample match the commercial process, and can one batch be traced from incoming plant material to the certificate of analysis delivered to the buyer?

WPE & WHPE 2026 gives international buyers a useful place to investigate those links. The event runs from 24 to 26 August 2026 at the Xi’an International Convention and Exhibition Center. Its official product structure separates natural ingredients under WPE, nutrition and health products under WHPE, and extraction, separation, drying, testing, packaging and other production technologies under the co-located PE-TECH platform. The organiser expects more than 700 exhibitors across 40,000 square metres; the completed 2025 edition reported 678 exhibitors and 26,000 professional visitors.

Xi’an also changes the value of the trip. Shaanxi’s market-regulation authority describes an established provincial plant-extract cluster and has highlighted production controls for extracts used as health-food ingredients. That makes a post-show supplier route commercially relevant—but only after the team has reduced the exhibition longlist to ingredients, specifications and actual plants worth checking.

Begin with the botanical identity, not the sales name

Before the show, prepare one requirement sheet for each ingredient or application. A request for “high-quality ginseng extract” or “natural antioxidant powder” is too open to interpretation. The working brief should state, as applicable:

accepted Latin binomial, common name and plant part;
geographic origin and whether cultivated or wild-collected material is acceptable;
extraction solvent and any prohibited processing aids;
extract ratio, native-extract content or marker-compound requirement;
assay basis, analytical method and reporting units;
physical form, particle size, colour, odour and solubility requirements;
carrier, excipient, anticaking agent or standardisation material permitted;
contaminant, microbiological and residual-solvent limits;
allergen, GMO, irradiation and treatment declarations required;
destination market, intended food, supplement, beverage, cosmetic or other application;
packaging, storage, shelf-life and annual-volume assumptions.

The scientific name alone is not enough. Closely related species, different plant parts and different growing regions can produce materially different chemical profiles. If the destination market restricts a botanical, dose, claim or application, resolve that issue with qualified regulatory advice before treating a supplier’s availability as evidence of market eligibility.

Follow one requirement through all three show layers

The exhibition’s full-chain structure is most useful when the buyer follows a single ingredient programme through the halls instead of collecting unrelated samples.

WPE: compare the ingredient itself

At ingredient stands, establish the identity of the product being offered. Record botanical source, plant part, origin, harvest or collection model, extraction route, standardisation method and commercial grade. Ask whether the exhibitor sells a native extract, a standardised extract, a blended formulation or a finished premix. These may use similar front-label language but create very different specification, labelling and cost implications.

Request a current specification, a representative certificate of analysis and the method used for the key assay. If a supplier presents several grades, note what actually changes: raw-material origin, solvent, concentration, active level, carrier, microbiological control, application testing or simply packaging and branding.

WHPE: see how the ingredient behaves in a finished format

The finished-product and OEM/ODM area can reveal problems that remain hidden on an ingredient data sheet. A powder may have strong assay results but poor dispersion, colour stability or taste in a beverage. A highly standardised extract may create tablet-weight, capsule-size or cost constraints. Gummies, meal replacements, functional drinks and other formats expose questions about dosage, texture, heat stability and interactions with other ingredients.

Use these discussions to refine the ingredient requirement. The objective is not automatically to buy the finished product; it is to understand whether the quoted extract works in the buyer’s intended format and whether the supplier has evidence from a comparable application.

PE-TECH: connect the specification to the process

Extraction, separation, purification, concentration, drying, fermentation, laboratory and packaging suppliers help the team test whether a product story is technically coherent. If an ingredient is described as low-temperature processed, solvent-free, highly purified or unusually soluble, ask which process steps produce that result and what the process must control.

This does not prove that an ingredient exhibitor uses the equipment displayed elsewhere in the hall. It gives the buyer better questions for the manufacturer: extraction temperature and time, solvent-to-material ratio, filtration or membrane stage, resin or chromatography controls, concentration conditions, drying method, yield range and management of rework or recovered solvent.

Build a chain from sample to commercial batch

Samples remain useful when their identity is preserved. Label every sample with the supplier, product code, grade, batch or lot number, date received and linked documents. Photograph the original packaging and record whether the material came from routine production, a pilot batch, a laboratory batch or a specially selected exhibition sample.

For each shortlisted product, try to connect five records:

the raw-material lot and approved source;
the manufacturing batch and process route;
the finished-extract lot and release decision;
the sample or retained sample evaluated by the buyer;
the quotation and specification proposed for commercial supply.

If the certificate of analysis cannot be tied to the sample, the test data may describe a different batch. If the quotation uses a different grade from the sample, a successful application trial does not validate the quoted material. The team should leave the stand knowing which exact product will move into testing and what would trigger a new approval.

Read the assay figure in context

An active-content percentage becomes commercially useful once the test basis is clear. Confirm the analytical method, sample preparation, reference standard, calculation basis and measurement uncertainty or normal variation where relevant. Ask whether the result is reported as-is or on a dry basis and whether it represents one marker compound, a group of compounds or a broader spectrophotometric estimate.

Chromatographic methods can be highly specific, but two laboratories can still use different columns, reference standards, integration rules or sample preparation. A supplier’s in-house method may be appropriate for process control while the buyer or destination market requires another recognised method for release. Agree which method governs the commercial specification and how discrepancies will be investigated.

Extract ratio deserves the same care. A stated 10:1 ratio does not by itself identify the plant part, starting moisture, extraction efficiency, carrier level or active content. Ask for the calculation and confirm whether the ratio describes raw material input, native extract or a commercial standardised powder.

Match contaminants and authenticity checks to the real risk

A generic promise of “all tests passed” provides little guidance. The control plan should reflect the botanical, origin, processing route and destination application. Depending on the material, relevant checks may include pesticide residues, heavy metals, microbiological limits, mycotoxins, residual solvents, polycyclic aromatic hydrocarbons, foreign matter or specific natural toxins.

Authenticity also requires a risk-based approach. Macroscopic or microscopic identification may suit incoming whole or cut material, while chemical fingerprinting, marker ratios, DNA methods or other techniques may be needed at different processing stages. No single method answers every authenticity question after extraction has changed or removed identifying features.

Ask how the supplier qualifies farms, collectors or raw-material traders; how lots are sampled; which tests are performed internally or by external laboratories; and what happens when results are atypical but still inside specification. A good discussion explains the reasoning behind the plan rather than presenting a thick file of unrelated certificates.

Choose the factory visit by product and plant

The legal seller, brand owner, extract manufacturer, contract processor and laboratory may be different organisations. Before arranging a visit, confirm which facility will manufacture the quoted grade and whether extraction, standardisation, blending, testing and packing occur there or at separate sites.

At the selected plant, follow one real or representative batch route:

raw-material receipt, quarantine, sampling and identity release;
storage conditions and separation of materials with different risk profiles;
weighing, extraction and control of time, temperature and solvent;
filtration, purification, concentration and drying;
milling, blending or standardisation with carriers;
in-process sampling and laboratory testing;
packaging, label control, finished-product release and retention samples;
waste, water, dust and solvent management where applicable;
deviation, change-control, complaint and traceability records.

Document the limits of each facility as carefully as its strengths. A clean blending and packing site may be one controlled part of the supply chain while extraction occurs elsewhere. Conversely, a capable extraction plant may rely on a qualified external laboratory for specialised tests. The sourcing decision should reflect the disclosed chain and the controls between organisations, without assuming that every step must sit under one roof.

Build a realistic Xi’an and Shaanxi route

The organiser promotes Xi’an as a major plant-extract hub and offers post-show business and industrial visits. Provincial sources also point to plant-extract, health-food and biomedicine activity across Xi’an, Xixian New Area, Yangling and other parts of Shaanxi. That is a useful regional base, but it is not a licence to schedule factories by city label alone.

Confirm each actual production address, travel time, visitor access, confidentiality rules and the technical people who will attend. Some commercial offices or laboratories may be in Xi’an while extraction occurs elsewhere in the province. Two suppliers described as “Xi’an companies” may require very different journeys.

A focused programme could use the three show days to reduce the longlist, followed by one day for a nearby plant and laboratory or a second day for a more distant production site. Two detailed visits usually provide more evidence than a rushed circuit of several reception rooms.

A six-day working sequence

23 August — align specifications and meetings

Review the botanical briefs, divide scientific, quality and commercial questions, and book meetings with the ingredient suppliers most relevant to the target applications. Prepare one comparison sheet and decide which documents may be accepted at the stand and which require controlled exchange after an NDA.

24 August — establish ingredient identity

Start in WPE. Compare botanical source, grade, assay basis, extraction route and raw-material controls. Reduce the longlist before the end of the day and request missing specifications or certificates in a consistent format.

25 August — connect application and process

Use WHPE to test how the ingredients perform in relevant finished formats, then use PE-TECH discussions to challenge claims about extraction, purification, drying, testing and packaging. Attend only the forum sessions that can resolve a live technical or regulatory question for the project.

26 August — close evidence gaps and confirm the route

Return to shortlisted suppliers. Link samples to batches and documents, confirm the legal seller and production facility, and agree the next sample or application trial. Finalise factory agendas, access and travel rather than accepting an open-ended invitation.

27–28 August — inspect selected facilities

At each plant, follow the exact grade under consideration. Check raw-material identity, process ownership, laboratory controls, traceability and change management. End each visit with a written list of evidence received, evidence promised and issues that must be resolved before quotation approval or pilot ordering.

Leave with a controlled ingredient decision

The strongest outcome from WPE & WHPE is not the largest bag of samples. It is a smaller set of ingredient candidates whose botanical identity, commercial grade, analytical basis, manufacturing site and intended application are connected.

For each candidate, define the next decision gate: document review, regulatory assessment, laboratory verification, application trial, stability work, pilot order, quality-system review or formal audit. Keep unverified marketing claims outside the purchasing specification. When the sample, certificate, quotation and factory all point to the same product, the Xi’an trip has produced a sourcing route that can survive beyond the exhibition hall.

Official sources and update

Event and regional-industry references checked 8 August 2026. Reconfirm registration, exhibitor appointments, factory addresses, sample status and destination-market requirements before travel or supplier approval.

WPE & WHPE 2026: How to Verify a Plant Extract Supply Chain in Xi’an